P71 Treatment patterns, healthcare resource utilization and related costs of patients with discoid lupus erythematosus (DLE) or subacute cutaneous lupus erythematosus (SCLE) in the United States: a cohort study in the Merative™ MarketScan® database

• Ying Sun,
• Benjamin F Chong,
• Caroline Foch,
• Sanjeev Roy,
• Dominika Weinelt,
• Sabrina de Souza,
• Xiaoxue Chen,
• Jeffrey M Muir

Affiliations

Ying Sun

Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China

Benjamin F Chong

Dermatology, The University of Texas Southwestern Medical Center, Dallas, Texas, USA

Caroline Foch

1Clinical Science Measurement, Merck Healthcare KGaA, Darmstadt, Germany

Sanjeev Roy

7Merck, Aubonne, Switzerland, a division of Merck KGaA, Darmstadt, Germany

Dominika Weinelt

2Global Patient Safety, Merck Healthcare KGaA, Darmstadt, Germany

Sabrina de Souza

1Clinical Science Measurement, Merck Healthcare KGaA, Darmstadt, Germany

Xiaoxue Chen

3North America Evidence and Value Development, EMD Serono, Inc., Rockland, MA, USA, an affiliate of Merck KGaA

Jeffrey M Muir

6Health Economics and Outcomes Research, Cytel, Inc., Toronto, Canada